2 minute read
Mar. 12, 2022
LY3154885: an Oral D1 Modulator
LY3154885
oral D1 modulator Ph. I candidate for neurological disorders opt. against DDI w/ hepatocyte Cl assay J. Med. Chem. Eli Lilly and Company
oral D1 modulator Ph. I candidate for neurological disorders opt. against DDI w/ hepatocyte Cl assay J. Med. Chem. Eli Lilly and Company